Cargando…
Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic
Objective: In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19) that resulted in a global pandemic with substantial morbidity and mortality. Currently, there is no specific treatment or app...
Autores principales: | Yuen, Kevin C.J., Blevins, Lewis S., Findling, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833469/ https://www.ncbi.nlm.nih.gov/pubmed/33471683 http://dx.doi.org/10.4158/EP-2020-0308 |
Ejemplares similares
-
Rethinking the management of immune checkpoint inhibitor‐related adrenal insufficiency in cancer patients during the COVID‐19 pandemic
por: Yuen, Kevin C. J., et al.
Publicado: (2021) -
Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2021) -
Burn management during the COVID-19 pandemic: recommendations and considerations
por: Soltany, Amjad, et al.
Publicado: (2020) -
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations
por: Bartlett, David L., et al.
Publicado: (2020) -
Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective
por: Fleseriu, Maria, et al.
Publicado: (2020)